ATYR: aTyr Pharma, Inc. Stock

by  •  • Comments Off on ATYR: aTyr Pharma, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 313.94
Enterprise Value ($M) 302.30
Book Value ($M) 65.14
Book Value / Share 0.78
Price / Book 4.82
NCAV ($M) 49.84
NCAV / Share 0.59
Price / NCAV 6.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.81
Return on Assets (ROA) -0.53
Return on Equity (ROE) -0.71

Liquidity (mrq)
Quick Ratio 5.41
Current Ratio 5.41

Balance Sheet (mrq) ($M)
Current Assets 76.32
Assets 91.62
Liabilities 26.48
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-08 13G/A Federated Hermes, Inc.
11-14 13G/A Logos Global Management LP 2.10 -69.83
10-15 13G Point72 Asset Management, L.P. 6.20
02-14 13G/A Lytton Laurence W 1.00 -86.82
02-13 13G/A Stonepine Capital Management, LLC 0.80 -89.83
02-09 13G/A Fmr Llc 15.00 101.87

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPO
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 108,640 673,918 16.12
2025-01-30 115,807 561,786 20.61
2025-01-29 109,506 471,363 23.23
2025-01-28 75,952 369,771 20.54

(click for more detail)

Similar Companies
ATNF – 180 Life Sciences Corp. ATOS – Atossa Therapeutics, Inc.
ATXI – Avenue Therapeutics, Inc. AVTX – Avalo Therapeutics, Inc.
AWH – Aspira Women's Health Inc.


Financial data and stock pages provided by
Fintel.io